CheckMate 204: 3-year outcomes of treatment with combination nivolumab (NIVO) plus ipilimumab (IPI) for patients (pts) with active melanoma brain metastases (MBM) Meeting Abstract
| Authors: | Tawbi, H. A.; Forsyth, P. A.; Hodi, F. S.; Algazi, A.; Hamid, O.; Lao, C. D.; Moschos, S. J.; Atkins, M. B.; Lewis, K.; Postow, M. A.; Thomas, R. P.; Khushalani, N. I.; Pavlick, A. C.; Ernstoff, M. S.; Reardon, D. A.; Chung, C.; Lee, W.; Bas, T.; Askelson, M.; Margolin, K. A. |
| Abstract Title: | CheckMate 204: 3-year outcomes of treatment with combination nivolumab (NIVO) plus ipilimumab (IPI) for patients (pts) with active melanoma brain metastases (MBM) |
| Meeting Title: | ESMO Congress 2021 |
| Journal Title: | Annals of Oncology |
| Volume: | 32 |
| Issue: | Suppl. 5 |
| Meeting Dates: | 2021 Sep 16-21 |
| Meeting Location: | Virtual |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2021-09-01 |
| Start Page: | S871 |
| End Page: | S872 |
| Language: | English |
| ACCESSION: | WOS:000700527702058 |
| DOI: | 10.1016/j.annonc.2021.08.1424 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract 1039MO -- Source: Wos |
